Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Extracorporeal Shock Wave Lithotripsy and Endoscopic Retrograde Cholangiopancreatography for Pancreatic Stones

NCT05916547 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT05916547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05916547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Extracorporeal Shock Wave Lithotripsy and Endoscopic Retrograde Cholangiopancreatography for Pancreatic Stones
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2023
Completion date
May 1, 2024
Enrollment
2,071 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic duct stone